Back to today’s briefing

Story perspectives

NHS Launches Talquetamab for Myeloma, Offers New Hope

11/19/2025

31 5

Summary

Story summary

The National Health Service (NHS) has made Talquetamab available to treat myeloma, offering a new option for this blood cancer.
Sue Harley, diagnosed with myeloma in 2017, accessed the drug through a compassionate use scheme.
After two years of treatment, she is now in remission.
Consultant haematologist Guy Pratt called Talquetamab a significant advancement.
He noted that up to 800 patients per year may benefit.

1 of 1

Story summary

The National Health Service (NHS) has made Talquetamab available to treat myeloma, offering a new option for this blood cancer.
Sue Harley, diagnosed with myeloma in 2017, accessed the drug through a compassionate use scheme.
After two years of treatment, she is now in remission.
Consultant haematologist Guy Pratt called Talquetamab a significant advancement.
He noted that up to 800 patients per year may benefit.